Your browser doesn't support javascript.
loading
Pegaspargase in Practice: Minimizing Toxicity, Maximizing Benefit.
Riley, David O; Schlefman, Jenna M; Vitzthum Von Eckstaedt V, Hans Christoph; Morris, Amy L; Keng, Michael K; El Chaer, Firas.
Afiliação
  • Riley DO; Department of Medicine, Division of Hematology and Oncology, University of Virginia School of Medicine, 1215 Lee Street, Charlottesville, VA, 22903, USA.
  • Schlefman JM; Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA, USA.
  • Vitzthum Von Eckstaedt V HC; University of Virginia School of Medicine, Charlottesville, VA, USA.
  • Morris AL; Department of Pharmacy Services, UVA Health, Charlottesville, VA, USA.
  • Keng MK; Department of Medicine, Division of Hematology and Oncology, University of Virginia School of Medicine, 1215 Lee Street, Charlottesville, VA, 22903, USA.
  • El Chaer F; Department of Medicine, Division of Hematology and Oncology, University of Virginia School of Medicine, 1215 Lee Street, Charlottesville, VA, 22903, USA. fe2gh@virginia.edu.
Curr Hematol Malig Rep ; 16(3): 314-324, 2021 06.
Article em En | MEDLINE | ID: mdl-33978914
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Asparaginase / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Asparaginase / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article